2 results
Approved WMOCompleted
Primary objective- To evaluate the efficacy of lenalidomide (RevlimidTM) in low/int-1 risk MDS with or without a treatment with Epo (NeoRecormonTM)/G-CSF (NeupogenTM) in terms of hematological improvement (HI) as defined by the modified response…
Approved WMOPending
The primary aim of this study is early identification of sepsis (and septic shock) and cardiovascular instability, based on the hemodynamic profile of ED patients. Continuous noninvasive arterial pressure waveform signals will be collected with the…